Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy [Phase 2, Phase 3]
Clinical trial update investigating magnesium sulfate added to bupivacaine for serratus anterior plane block in modified radical mastectomy;…
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Neoadjuvant Radiation in Locally Advanced Breast Cancer [Phase 2]
Phase 2 trial update investigating neoadjuvant radiation in locally advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-28Clinical Trial Update: Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating tolerability of combining lapatinib with trastuzumab in adults aged 60 and older with HER2-positive locally advance…
-
CLINICAL_TRIALS trial_result · 2022-07-27Clinical Trial Update: LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients [Phase 1, Phase 2]
Clinical trial update for LUT014 evaluating its use in radiation-induced dermatitis in breast cancer patients across Phase 1 and Phase 2, wi…
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer [Phase 2]
Phase 2 trial update evaluating nab-paclitaxel in older patients with locally advanced or metastatic breast cancer; results have been posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer [Phase 2]
Phase 2 umbrella study evaluating molecularly targeted therapies in luminal advanced breast cancer; status not specified in available data.
-
CLINICAL_TRIALS trial_result · 2022-07-22Clinical Trial Update: Dalpiciclib Plus Letrozole and Capecitabine [Phase 2]
Phase 2 trial update of dalpiciclib in combination with letrozole and capecitabine for advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-20Clinical Trial Update: Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer [NA]
This clinical trial evaluates whether Cu-64-DOTA-Trastuzumab PET imaging can predict response to ado-trastuzumab emtansine in metastatic HER…
-
CLINICAL_TRIALS trial_result · 2022-07-12Clinical Trial Update: Carvedilol for the Prevention of Anthracycline/Anti-HER2 Therapy Associated Cardiotoxicity Among Women With HER2-Positive Breast Cancer Using Myocardial Strain Imaging for Early Risk Stratification [Phase 2]
A Phase 2 trial evaluating carvedilol to prevent cardiotoxicity from anthracycline and anti-HER2 therapy in women with HER2-positive breast …
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. [Phase 3]
A Phase 3 randomized, double-blind trial evaluating FCN-437c plus letrozole or anastrozole (± goserelin) versus placebo in HR+/HER2- advance…
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Neoadjuvant Inituomab, Pyrrolidone and Nab-paclitaxel for HER2+Breast Cancer [Phase 2]
A Phase 2 trial update for neoadjuvant therapy combining Inituomab, Pyrrolidone, and Nab-paclitaxel in HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c in Combination With Fluvestrant ± Goseraline Versus Placebo Combined With Fulvestrant ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer. [Phase 3]
Phase III randomized trial evaluating FCN-437c in combination with fulvestrant ± goserelin versus placebo with fulvestrant ± goserelin in HR…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: A Study for the Adjuvant Treatment of Breast Cancer [Phase 4]
Phase 4 clinical trial updating adjuvant treatment for breast cancer; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: A Study for the Neoadjuvant Treatment of Breast Cancer [Phase 4]
A Phase 4 clinical trial update for neoadjuvant treatment of breast cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Study of the Effect of the Addition of SNDX-275 (Entinostat) to Continued Aromatase Inhibitor (AI) Therapy in Postmenopausal Women With ER+ Breast Cancer Whose Disease is Progressing [Phase 2]
Phase 2 trial evaluating adding entinostat to continued aromatase inhibitor therapy in postmenopausal women with ER-positive breast cancer p…
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR) [Phase 2]
Phase 2 clinical trial of orteronel as monotherapy in patients with metastatic breast cancer expressing the androgen receptor has completed …
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer [Phase 2]
Phase 2 window study comparing amcenestrant (SAR439859) to letrozole in postmenopausal ER-positive, HER2-negative breast cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Predictors for Response to Dose-dense Docetaxel and Epirubicin Breast Cancer [Phase 2]
Phase 2 study evaluating predictors of response to dose-dense docetaxel and epirubicin in Stage III breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: To Enhance Breast Cancer Survivorship of Asian Americans [NA]
A completed clinical trial conducted by Emory University focused on enhancing survivorship for Asian American breast cancer patients; result…
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer [Phase 3]
Phase 3 clinical trial update for a precise therapy in refractory HER2-positive advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Novel Double Target Therapy Combined With Chemotherapy in First-line Treatment of HER2+ Breast Cancer, MA-BC-II-038 [Phase 2]
Phase 2 trial update on a novel double-target therapy combined with chemotherapy for first-line treatment of HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer [Phase 2]
Phase 2 trial update of KN026 in combination with docetaxel as neoadjuvant therapy for HER2-positive breast cancer (status unknown).
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Phase 2 Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer [Phase 2]
Phase 2 trial update for KHK2375 in advanced or recurrent breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC [Phase 2]
Phase 2 clinical trial investigating molecular mechanisms of resistance and sensitivity to palbociclib re-challenge in ER-positive metastati…
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab [Phase 1, Phase 2]
A Phase 1/2 trial evaluating a vaccine therapy in combination with trastuzumab for patients with Stage IV HER2-positive breast cancer or ova…